Based on the Ban Loong Holdings Ltd stock forecast from 0 analysts, the average analyst target price for Ban Loong Holdings Ltd is not available over the next 12 months. Ban Loong Holdings Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Ban Loong Holdings Ltd is Bearish, which is based on 2 positive signals and 8 negative signals. At the last closing, Ban Loong Holdings Ltd’s stock price was HKD 0.145. Ban Loong Holdings Ltd’s stock price has changed by -5.23% over the past week, -19.44% over the past month and -41.77% over the last year.
No recent analyst target price found for Ban Loong Holdings Ltd
No recent average analyst rating found for Ban Loong Holdings Ltd
Company Overview Ban Loong Holdings Ltd
YNBY International Limited, an investment holding company, engages in the e-commerce trading business in Hong Kong, the People's Republic of China, and internationally. It is involved in the raw materials trading business for healthcare products, including sourcing of packaging materials, pharmacy and cosmetics CBD materials, plant extracts, etc.; and manufacturing of cosmetics and healthcare products, as well as related packaging materials. The company also supplies other plant extracts and raw materials comprising packaging materials, sorbitol, steviol glycoside, lauric acid, CBD materials, glycerin, etc. for the healthcare and cosmetics industry; and offers marketing services, product and intellectual property registration services, and sourcing services for original equipment manufacturers (OEM)/ original design manufactures (ODM). The company was formerly known as Ban Loong Holdings Limited and changed its name to YNBY International Limited in September 2023. YNBY International Limited was founded in 1971 and is based in Quarry Bay, Hong Kong. Address: 32/F, Quarry Bay, Hong Kong Read Less
YNBY International Limited, an investment holding company, engages in the e-commerce trading business in Hong Kong, the People's Republic of China, and internationally. It is involved in the raw materials trading business for healthcare products, including sourcing of packaging m...Read More
Frequently Asked Questions About Ban Loong Holdings Ltd (0030:HK) Stock
Stock Target Advisor's fundamental analysis for Ban Loong Holdings Ltd's stock is Bearish.
Unfortunately we do not have enough data on 0030:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0030:HK's stock to indicate what its average analyst target is.
0030:HK stock's Price/Earning ratio is 129.02.
Our analysis grades 0030:HK stock's Price / Earning ratio at F. This means that 0030:HK stock's Price/Earning ratio is above 87% of the stocks in the Capital Markets sector in the HK exchange.
Based on this 0030:HK may be a overvalued for its sector.
The last closing price of 0030:HK's stock was HKD 0.15.
The most recent market capitalization for 0030:HK is HKD 1.00B.
Unfortunately we do not have enough analyst data on 0030:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Ban Loong Holdings Ltd's stock.
As per our most recent records Ban Loong Holdings Ltd has 43 Employees.
Ban Loong Holdings Ltd's registered address is China Resources Building, Wan Chai, Hong Kong.
You can get more information about it from Ban Loong Holdings Ltd's website at https://www.0030hk.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0030:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
